Treats Major Depressive Disorder (MDD). ANDA 76006, held by Dr Reddys. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 76006 (Fluoxetine Hydrochloride), held by Dr Reddys, was first approved by FDA on Jan 30, 2002, with 9 approved supplements and 0 published complete response letters.
Fluoxetine is a a selective serotonin reuptake inhibitor indicated for: Acute and maintenance treatment of Major Depressive Disorder (MDD) in adult and pediatric patients aged 8 to 18 years Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) in adults and pediatric patients aged 7 to 17 years Acute and maintenance treatment of Bulimia Nervosa in adult patients Acute treatment of Panic Disorder, with or without agoraphobia, in adult patients 1.1 Major Depressive Disorder Fluoxetine tablets are indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to18 years.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 2002 | Original application | Approved | None posted |
| Fluoxetine HydrochlorideEQ 10MG BASE · tablet;oral | Fluoxetine Hydrochloride | Rx |
| Fluoxetine HydrochlorideEQ 20MG BASE · tablet;oral | Fluoxetine Hydrochloride | Rx |
| Aug 18, 2023 | Supplement 12Labeling · Standard review | Approved | None posted |
| Sep 20, 2021 | Supplement 9Labeling · Standard review | Approved | None posted |
| Aug 25, 2021 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 28, 2016 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 4Labeling · Standard review | Approved | None posted |
| May 10, 2010 | Supplement 3Labeling | Approved | None posted |
| Aug 21, 2009 | Supplement 2Labeling | Approved | None posted |
| Jan 25, 2007 | Supplement 1Labeling | Approved | None posted |
| Jan 30, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters